AU2019365821C1 - Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus - Google Patents

Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus

Info

Publication number
AU2019365821C1
AU2019365821C1 AU2019365821A AU2019365821A AU2019365821C1 AU 2019365821 C1 AU2019365821 C1 AU 2019365821C1 AU 2019365821 A AU2019365821 A AU 2019365821A AU 2019365821 A AU2019365821 A AU 2019365821A AU 2019365821 C1 AU2019365821 C1 AU 2019365821C1
Authority
AU
Australia
Prior art keywords
amplifying
virus
compositions
detecting
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019365821A
Other languages
English (en)
Other versions
AU2019365821A1 (en
AU2019365821B9 (en
AU2019365821B2 (en
Inventor
Ankur Shah
Meghna YADAV
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of AU2019365821A1 publication Critical patent/AU2019365821A1/en
Application granted granted Critical
Publication of AU2019365821B2 publication Critical patent/AU2019365821B2/en
Priority to AU2025202979A priority Critical patent/AU2025202979A1/en
Publication of AU2019365821B9 publication Critical patent/AU2019365821B9/en
Publication of AU2019365821C1 publication Critical patent/AU2019365821C1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2019365821A 2018-10-22 2019-10-22 Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus Active AU2019365821C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025202979A AU2025202979A1 (en) 2018-10-22 2025-04-29 Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862748998P 2018-10-22 2018-10-22
US62/748,998 2018-10-22
PCT/US2019/057383 WO2020086546A1 (en) 2018-10-22 2019-10-22 Compositions and methods for amplifying, detecting or quantifying human polyomavirus bk virus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025202979A Division AU2025202979A1 (en) 2018-10-22 2025-04-29 Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus

Publications (4)

Publication Number Publication Date
AU2019365821A1 AU2019365821A1 (en) 2021-06-10
AU2019365821B2 AU2019365821B2 (en) 2025-03-13
AU2019365821B9 AU2019365821B9 (en) 2025-07-03
AU2019365821C1 true AU2019365821C1 (en) 2025-08-14

Family

ID=68502056

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019365821A Active AU2019365821C1 (en) 2018-10-22 2019-10-22 Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus
AU2025202979A Pending AU2025202979A1 (en) 2018-10-22 2025-04-29 Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025202979A Pending AU2025202979A1 (en) 2018-10-22 2025-04-29 Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus

Country Status (7)

Country Link
US (3) US12054793B2 (https=)
EP (1) EP3870722A1 (https=)
JP (2) JP7542546B2 (https=)
CN (1) CN113195743A (https=)
AU (2) AU2019365821C1 (https=)
CA (1) CA3116895A1 (https=)
WO (1) WO2020086546A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014197607A1 (en) * 2013-06-05 2014-12-11 The Regents Of The University Of California Detection of tick-borne diseases

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422956A1 (fr) 1978-04-13 1979-11-09 Pasteur Institut Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
US4786600A (en) 1984-05-25 1988-11-22 The Trustees Of Columbia University In The City Of New York Autocatalytic replication of recombinant RNA
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
WO1988001302A1 (en) 1986-08-11 1988-02-25 Siska Diagnostics, Inc. Nucleic acid probe assay methods and compositions
US5541308A (en) 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
DE3854029T2 (de) 1987-09-21 1995-10-26 Gen Probe Inc Homogener Abschirmungstest.
US5639604A (en) 1987-09-21 1997-06-17 Gen-Probe Incorporated Homogeneous protection assay
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5185439A (en) 1987-10-05 1993-02-09 Gen-Probe Incorporated Acridinium ester labelling and purification of nucleotide probes
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5656207A (en) 1989-06-24 1997-08-12 Gen Probe Incorporated Detecting or quantifying multiple analytes using labelling techniques
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5849481A (en) 1990-07-27 1998-12-15 Chiron Corporation Nucleic acid hybridization assays employing large comb-type branched polynucleotides
JP3131222B2 (ja) 1991-12-24 2001-01-31 アイシス・ファーマシューティカルス・インコーポレーテッド ギャップを有する2′修飾オリゴヌクレオチド
US5424413A (en) 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
KR100249110B1 (ko) 1992-05-06 2000-04-01 다니엘 엘. 캐시앙 핵산 서열 증폭 방법, 이에 이용되는 조성물 및 키트
CA2141430C (en) 1992-08-04 2009-05-12 Sherrol H. Mcdonough Nucleic acid sequence amplification
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
WO1995003430A1 (en) 1993-07-23 1995-02-02 Gen-Probe Incorporated Methods for enhancing nucleic acid amplification
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
JPH10500310A (ja) 1994-05-19 1998-01-13 ダコ アクティーゼルスカブ 淋菌及びトラコーマ クラミジアの検出のためのpna プローブ
DE69535240T2 (de) 1994-10-28 2007-06-06 Gen-Probe Inc., San Diego Zusammensetzungen und Verfahren für die gleichzeitige Detektion und Quantifizierung von einer Mehrheit spezifischer Nuklein Säure Sequenzen
US5731148A (en) 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
AU713667B2 (en) 1996-04-12 1999-12-09 Phri Properties, Inc. Detection probes, kits and assays
EP0975807B1 (en) 1997-05-02 2006-09-27 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
US6180340B1 (en) 1997-10-31 2001-01-30 Gen-Probe Incorporated Extended dynamic range assays
AU762728B2 (en) 1998-07-02 2003-07-03 Gen-Probe Incorporated Molecular torches
CA2572472C (en) 2004-07-01 2013-08-13 Gen-Probe Incorporated Methods and compositions to detect nucleic acids in a biological sample
US20060194240A1 (en) 2005-02-28 2006-08-31 Gen-Probe Incorporated Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe
US7892795B2 (en) 2005-08-02 2011-02-22 Focus Diagnostics, Inc. Methods and compositions for detecting BK virus
EP1957678B1 (en) 2005-11-28 2012-06-13 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
US9051601B2 (en) 2006-08-01 2015-06-09 Gen-Probe Incorporated Methods of nonspecific target capture of nucleic acids
US20090246754A1 (en) 2008-02-19 2009-10-01 Intelligent Mdx Optimized probes and primers and methods of using same for the detection and quantitation of bk virus
US20110091866A1 (en) * 2008-02-20 2011-04-21 Kosuke Ken Iwaki Detection of polyomavirus
US8346485B2 (en) 2008-11-25 2013-01-01 Quest Diagnostics Investments Incorporated Methods and apparatuses for estimating initial target nucleic acid concentration in a sample by modeling background signal and cycle-dependent amplification efficiency of a polymerase chain reaction
US20130267429A1 (en) 2009-12-21 2013-10-10 Lawrence Livermore National Security, Llc Biological sample target classification, detection and selection methods, and related arrays and oligonucleotide probes
EP3052644B1 (en) 2013-10-01 2019-07-10 Texcell Detection of rare microbiological nucleic acids
WO2017040316A1 (en) 2015-08-28 2017-03-09 The Broad Institute, Inc. Sample analysis, presence determination of a target sequence
CN105925678B (zh) * 2016-05-06 2021-10-12 艾吉泰康生物科技(北京)有限公司 用于扩增样品中多个目标dna序列的引物组及其应用
US10793923B2 (en) 2016-11-09 2020-10-06 Roche Molecular Systems, Inc. Compositions and methods for detection of BK virus
WO2020007261A1 (en) 2018-07-02 2020-01-09 Huawei Technologies Co., Ltd. V refinement of video motion vectors in adjacent video data
CN110684861B (zh) 2018-07-05 2023-10-27 上海公卫生物医药有限公司 一种用于bkv的早期诊断和检测体系及其应用
CN111733298B (zh) 2020-08-25 2020-11-20 圣湘生物科技股份有限公司 检测多瘤病毒并分型的组合物、试剂盒、方法及其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014197607A1 (en) * 2013-06-05 2014-12-11 The Regents Of The University Of California Detection of tick-borne diseases

Also Published As

Publication number Publication date
CN113195743A (zh) 2021-07-30
JP2024164112A (ja) 2024-11-26
WO2020086546A1 (en) 2020-04-30
US20240352545A1 (en) 2024-10-24
AU2019365821A1 (en) 2021-06-10
AU2019365821B9 (en) 2025-07-03
US20240336985A1 (en) 2024-10-10
JP7542546B2 (ja) 2024-08-30
AU2025202979A1 (en) 2025-05-22
US12054793B2 (en) 2024-08-06
AU2019365821B2 (en) 2025-03-13
US12486546B2 (en) 2025-12-02
US12359267B2 (en) 2025-07-15
JP2022508954A (ja) 2022-01-19
EP3870722A1 (en) 2021-09-01
CA3116895A1 (en) 2020-04-30
US20220010388A1 (en) 2022-01-13

Similar Documents

Publication Publication Date Title
EP3907218A4 (en) 6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, METHOD FOR PREPARATION AND MEDICAL USE
EP3870217A4 (en) MUTANT VACCINIA VIRUSES AND USE THEREOF
SG11202109423TA (en) Systems, compositions, and methods for target entity detection
HK1255192A1 (zh) 表达细胞因子和羧酸酯酶的修饰的溶瘤痘苗病毒及其使用方法
EP3947667A4 (en) MODIFIED CLEAVASE, USES THEREOF AND RELATED KITS
EP3640248B8 (en) Aminopyrimidine derivatives, preparation method therefor and use thereof
EP3878956A4 (en) MODIFIED CAS9 PROTEIN AND RELATED USE
EP4021928A4 (en) MODIFIED N-810 AND ASSOCIATED METHODS
IL288856A (en) Compositions, kits, methods and uses for preventing microbial growth
EP3216879A4 (en) Pna probe, kit and method for detecting human papillomavirus genotype
EP4082534A4 (en) SOLID PREPARATION, ITS PREPARATION METHOD AND ITS USE
EP4295903A3 (en) Compositions and methods for treating farber disease
EP3990918A4 (en) ANEMIA AND BLOOD DETECTION COMPOSITIONS AND METHODS
EP3950693A4 (en) THIENOHETEROCYCLIC DERIVATIVE, METHOD FOR PREPARING IT AND ITS MEDICAL USE
WO2021194580A3 (en) Riboregulators and methods of use thereof
SG11202105823TA (en) Compositions and methods for detecting human papillomavirus
EP3875110A4 (en) MODIFIED CMV GB PROTEIN AND CMV VACCINE WITH IT
AU2019365821C1 (en) Compositions and methods for amplifying, detecting or quantifying human polyomavirus BK virus
HK40050725A (en) Compositions and methods for amplifying, detecting or quantifying human polyomavirus bk virus
EP3824276A4 (en) COLORIMETRIC SENSORS AND METHODS AND USES THEREOF
GB201910299D0 (en) Medical uses, methods and uses
GB201907832D0 (en) Medical uses, methods and uses
HK40064129A (en) Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus
CA3241799A1 (en) Compositions and methods for detecting or quantifying parainfluenza virus
HK40060441B (en) Compositions and methods for amplifying or detecting varicella-zoster virus

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 23 APR 2025

SREP Specification republished
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 23 APR 2025

FGA Letters patent sealed or granted (standard patent)